Literature DB >> 16275996

Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak.

Shivendra V Singh1, Yan Zeng, Dong Xiao, Victor G Vogel, Joel B Nelson, Rajiv Dhir, Yamini B Tripathi.   

Abstract

The present study was undertaken to gain insights into the molecular mechanism of cell death (apoptosis) by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, using PC-3 human prostate cancer cells as a model. The viability of PC-3 cells, but not a normal prostate epithelial cell line (PrEC), was reduced significantly on treatment with guggulsterone in a concentration-dependent manner. Guggulsterone-mediated suppression of PC-3 cell proliferation was not due to perturbation in cell cycle progression but caused by apoptosis induction characterized by appearance of subdiploid cells and cytoplasmic histone-associated DNA fragmentation. Guggulsterone-induced apoptosis was associated with induction of multidomain proapoptotic Bcl-2 family members Bax and Bak. Interestingly, the expression of antiapoptotic proteins Bcl-2 and Bcl-xL was initially increased in guggulsterone-treated PC-3 cells but declined markedly following a 16- to 24-hour treatment with guggulsterone. Ectopic expression of Bcl-2 in PC-3 cells failed to confer significant protection against guggulsterone-induced cell death. On the other hand, SV40 immortalized mouse embryonic fibroblasts derived from Bax-Bak double knockout mice were significantly more resistant to guggulsterone-induced cell killing compared with wild-type cells. Guggulsterone treatment resulted in cleavage (activation) of caspase-9, caspase-8, and caspase-3, and guggulsterone-induced cell death was significantly attenuated in the presence of general caspase inhibitor as well as specific inhibitors of caspase-9 and caspase-8. In conclusion, the present study indicates that caspase-dependent apoptosis by guggulsterone is mediated in part by Bax and Bak.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275996     DOI: 10.1158/1535-7163.MCT-05-0223

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  20 in total

1.  [Aspects of traditional Indian medicine (Ayurveda) in urology].

Authors:  J Mani; S Kumar; G J Dobos; A Haferkamp
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

2.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

3.  Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway.

Authors:  Juan-Juan Shi; Xiao-Li Jia; Mei Li; Ning Yang; Ya-Ping Li; Xin Zhang; Ning Gao; Shuang-Suo Dang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

4.  Reactive oxygen species-dependent apoptosis by gugulipid extract of Ayurvedic medicine plant Commiphora mukul in human prostate cancer cells is regulated by c-Jun N-terminal kinase.

Authors:  Dong Xiao; Yan Zeng; Lakshmi Prakash; Vladmir Badmaev; Muhammed Majeed; Shivendra V Singh
Journal:  Mol Pharmacol       Date:  2010-11-29       Impact factor: 4.436

5.  Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.

Authors:  Moon Hee Yang; Kyu Taek Lee; Sera Yang; Jong Kyoon Lee; Kwang Hyuck Lee; Il Hwan Moon; Jong Chul Rhee
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-15       Impact factor: 4.553

6.  Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products.

Authors:  Shishir Shishodia; Gautam Sethi; Kwang Seok Ahn; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-03-30       Impact factor: 5.858

7.  Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Authors:  Rebecca J Leeman-Neill; Sarah E Wheeler; Shivendra V Singh; Sufi M Thomas; Raja R Seethala; Daniel B Neill; Mary C Panahandeh; Eun-Ryeong Hahm; Sonali C Joyce; Malabika Sen; Quan Cai; Maria L Freilino; Changyou Li; Daniel E Johnson; Jennifer R Grandis
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

8.  Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.

Authors:  Muzafar A Macha; Satyanarayana Rachagani; Suprit Gupta; Priya Pai; Moorthy P Ponnusamy; Surinder K Batra; Maneesh Jain
Journal:  Cancer Lett       Date:  2013-08-03       Impact factor: 8.679

9.  Obesity and endoplasmic reticulum (ER) stresses.

Authors:  Yamini B Tripathi; Vivek Pandey
Journal:  Front Immunol       Date:  2012-08-07       Impact factor: 7.561

10.  Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cells.

Authors:  Muzafar A Macha; Ajay Matta; Shyam Singh Chauhan; K W Michael Siu; Ranju Ralhan
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.